CFRXQ — CONTRAFECT Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$5.41m
Annual cashflow statement for CONTRAFECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.7 | -12.8 | -28.2 | -20.3 | -65.2 |
| Depreciation | |||||
| Non-Cash Items | 9.25 | -13.1 | -2.93 | -22.8 | 5.26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.02 | -1.71 | -2.27 | 1.76 | 13.8 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -26.3 | -27.4 | -33.2 | -41.1 | -46 |
| Capital Expenditures | -0.133 | -0.02 | 0 | 0 | -0.062 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 17.3 | 22 | -27.4 | -11.6 | 32.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 17.2 | 22 | -27.4 | -11.6 | 32.1 |
| Financing Cash Flow Items | -1.07 | -1.71 | -3.64 | -3.7 | -0.851 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 10.4 | 21.3 | 51.9 | 53.9 | 6.14 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.33 | 15.9 | -8.7 | 1.17 | -7.75 |